178 related articles for article (PubMed ID: 38579001)
1. Disrupted de novo pyrimidine biosynthesis impairs adult hippocampal neurogenesis and cognition in pyridoxine-dependent epilepsy.
Yan J; Wu J; Xu M; Wang M; Guo W
Sci Adv; 2024 Apr; 10(14):eadl2764. PubMed ID: 38579001
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy.
Crowther LM; Poms M; Zandl-Lang M; Abela L; Hartmann H; Seiler M; Mathis D; Plecko B
J Inherit Metab Dis; 2023 Jan; 46(1):129-142. PubMed ID: 36225138
[TBL] [Abstract][Full Text] [Related]
3. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.
Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR
Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477
[TBL] [Abstract][Full Text] [Related]
4. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM
J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine-Dependent Epilepsy in Zebrafish Caused by Aldh7a1 Deficiency.
Pena IA; Roussel Y; Daniel K; Mongeon K; Johnstone D; Weinschutz Mendes H; Bosma M; Saxena V; Lepage N; Chakraborty P; Dyment DA; van Karnebeek CDM; Verhoeven-Duif N; Bui TV; Boycott KM; Ekker M; MacKenzie A
Genetics; 2017 Dec; 207(4):1501-1518. PubMed ID: 29061647
[TBL] [Abstract][Full Text] [Related]
6. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet.
Mercimek-Mahmutoglu S; Cordeiro D; Cruz V; Hyland K; Struys EA; Kyriakopoulou L; Mamak E
Eur J Paediatr Neurol; 2014 Nov; 18(6):741-6. PubMed ID: 25127453
[TBL] [Abstract][Full Text] [Related]
7. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.
Engelke UF; van Outersterp RE; Merx J; van Geenen FA; van Rooij A; Berden G; Huigen MC; Kluijtmans LA; Peters TM; Al-Shekaili HH; Leavitt BR; de Vrieze E; Broekman S; van Wijk E; Tseng LA; Kulkarni P; Rutjes FP; Mecinović J; Struys EA; Jansen LA; Gospe SM; Mercimek-Andrews S; Hyland K; Willemsen MA; Bok LA; van Karnebeek CD; Wevers RA; Boltje TJ; Oomens J; Martens J; Coene KL
J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34138754
[TBL] [Abstract][Full Text] [Related]
8. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).
Mills PB; Footitt EJ; Mills KA; Tuschl K; Aylett S; Varadkar S; Hemingway C; Marlow N; Rennie J; Baxter P; Dulac O; Nabbout R; Craigen WJ; Schmitt B; Feillet F; Christensen E; De Lonlay P; Pike MG; Hughes MI; Struys EA; Jakobs C; Zuberi SM; Clayton PT
Brain; 2010 Jul; 133(Pt 7):2148-59. PubMed ID: 20554659
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary lysine restriction and arginine supplementation in two patients with pyridoxine-dependent epilepsy.
Yuzyuk T; Thomas A; Viau K; Liu A; De Biase I; Botto LD; Pasquali M; Longo N
Mol Genet Metab; 2016 Jul; 118(3):167-172. PubMed ID: 27324284
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1.
Mahajnah M; Corderio D; Austin V; Herd S; Mutch C; Carter M; Struys E; Mercimek-Mahmutoglu S
Pediatr Neurol; 2016 Jul; 60():60-5. PubMed ID: 27212567
[TBL] [Abstract][Full Text] [Related]
11. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.
Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S
Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480
[TBL] [Abstract][Full Text] [Related]
12. Novel homozygous missense mutation in ALDH7A1 causes neonatal pyridoxine dependent epilepsy.
Coci EG; Codutti L; Fink C; Bartsch S; Grüning G; Lücke T; Kurth I; Riedel J
Mol Cell Probes; 2017 Apr; 32():18-23. PubMed ID: 27856333
[TBL] [Abstract][Full Text] [Related]
13. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426
[TBL] [Abstract][Full Text] [Related]
14. Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.
Kava MP; Bryant L; Rowe P; Lewis B; Greed L; Balasubramaniam S
JIMD Rep; 2020 Jul; 54(1):9-15. PubMed ID: 32685344
[TBL] [Abstract][Full Text] [Related]
15. The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy.
Coughlin CR; Swanson MA; Spector E; Meeks NJL; Kronquist KE; Aslamy M; Wempe MF; van Karnebeek CDM; Gospe SM; Aziz VG; Tsai BP; Gao H; Nagy PL; Hyland K; van Dooren SJM; Salomons GS; Van Hove JLK
J Inherit Metab Dis; 2019 Mar; 42(2):353-361. PubMed ID: 30043187
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL
Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546
[TBL] [Abstract][Full Text] [Related]
17. Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy.
Mercimek-Mahmutoglu S; Horvath GA; Coulter-Mackie M; Nelson T; Waters PJ; Sargent M; Struys E; Jakobs C; Stockler-Ipsiroglu S; Connolly MB
Pediatrics; 2012 May; 129(5):e1368-72. PubMed ID: 22529283
[TBL] [Abstract][Full Text] [Related]
18. Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics.
Kuhara T; Akiyama T; Ohse M; Koike T; Shibasaki J; Imai K; Cooper AL
Anal Biochem; 2020 Sep; 604():113739. PubMed ID: 32339489
[TBL] [Abstract][Full Text] [Related]
19. Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy.
Tseng LA; Abdenur JE; Andrews A; Aziz VG; Bok LA; Boyer M; Buhas D; Hartmann H; Footitt EJ; Grønborg S; Janssen MCH; Longo N; Lunsing RJ; MacKenzie AE; Wijburg FA; Gospe SM; Coughlin CR; van Karnebeek CDM
Mol Genet Metab; 2022 Apr; 135(4):350-356. PubMed ID: 35279367
[TBL] [Abstract][Full Text] [Related]
20. Current knowledge for pyridoxine-dependent epilepsy: a 2016 update.
Pena IA; MacKenzie A; Van Karnebeek CDM
Expert Rev Endocrinol Metab; 2017 Jan; 12(1):5-20. PubMed ID: 30058881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
